Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

2-fucosyllactose - Intrinsic Medicine

Next Previous
Drug Profile

2-fucosyllactose - Intrinsic Medicine

Alternative Names: 2-FL; OM-002

Latest Information Update: 20 Aug 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Intrinsic Medicine
  • Class Anti-inflammatories; Behavioural disorder therapies; Oligosaccharides; Prebiotics; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Constipation; Diarrhoea; Inflammatory bowel diseases; Pervasive child development disorders; Solid tumours

Most Recent Events

  • 20 Aug 2024 Preclinical trials in Solid tumours in USA (PO) before August 2024 (Intrinsic Medicine pipeline, August 2024)
  • 20 Aug 2024 Intrinsic Medicine receives Human Research Ethics Committees approval to conduct phase II trial for 2-fucosyllactose for the treatment of Parkinson's disease (Intrinsic Medicine pipeline, August 2024)
  • 20 Aug 2024 Pharmacodynamics data from a preclinical trial in Solid tumours released by Intrinsic Medicine (Intrinsic Medicine pipeline, August 2024)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top